Eckert & Ziegler Brazil signs TerThera supply deal for GMP — grade terbium — 161 precursor

Eckert & Ziegler Brazil signed a strategic supply agreement with TerThera for GMP-compliant non-carrier-added terbium-161 precursor. Deal sets up a dedicated supply chain for Tb-161 in South America, targeting faster access to radioligand therapies in Brazil. Agreement supports local radiopharmaceutical development using Tb-161, focusing on oncology programs such as peptides or antibodies. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eckert & Ziegler SE published the original content used to generate this news brief on October 13, 2026, and is solely responsible for the information contained therein. (C)